1.Zhu, Y, Pandya, BJ & Choi, HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63, 3136–3141.
2.Trifirò, G, Morabito, P, Cavagna, L, et al. (2013) Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis 72, 694–700.
3.Uaratanawong, S, Suraamornkul, S, Angkeaw, S, et al. (2011) Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol 30, 887–893.
4.Chuang, SY, Lee, SC, Hsieh, YT, et al. (2011) Trends in hyperuricemia and gout prevalence: nutrition and health survey in Taiwan from 1993–1996 to 2005–2008. Asia Pac J Clin Nutr 20, 301–308.
5.Liu, R, Han, C, Wu, D, et al. (2015) Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015, 762820.
6.Roddy, E & Doherty, M (2010) Epidemiology of gout. Arthritis Res Ther 12, 223.
7.Sluijs, I, Beulens, JW, van der, ADL, et al. (2013) Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr 143, 80–85.
8.Yoo, TW, Sung, KC, Shin, HS, et al. (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69, 928–933.
9.Okura, T, Higaki, J, Kurata, M, et al. (2009) Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 73, 885–891.
10.de Oliveira, EP & Burini, RC (2012) High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 4, 12.
11.Cao, J, Zhang, J, Li, Q, et al. (2019) Serum phosphate and the risk of new-onset hyperuricemia in hypertensive patients. Hypertension 74, 102–110.
12.Wu, J, Xun, P, Tang, Q, et al. (2017) Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J 16, 60.
13.Schwalfenberg, GK & Genuis, SJ (2017) The importance of magnesium in clinical healthcare. Scientifica (Cairo) 2017, 4179326.
14.Hruby, A, Ngwa, JS, Renstrom, F, et al. (2013) Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies. J Nutr 143, 345–353.
15.Wark, PA, Lau, R, Norat, T, et al. (2012) Magnesium intake and colorectal tumor risk: a case–control study and meta-analysis. Am J Clin Nutr 96, 622–631.
16.Massy, ZA, Nistor, I, Apetrii, M, et al. (2016) Magnesium-based interventions for normal kidney function and chronic kidney disease. Magnes Res 29, 126–140.
17.Chiuve, SE, Korngold, EC, Januzzi, JL Jr, et al. (2011) Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 93, 253–260.
18.Zeng, C, Wang, YL, Wei, J, et al. (2015) Association between low serum magnesium concentration and hyperuricemia. Magnes Res 28, 56–63.
19.Wang, YL, Zeng, C, Wei, J, et al. (2015) Association between dietary magnesium intake and hyperuricemia. PLOS ONE 10, e0141079.
20.Zhang, Y & Qiu, H (2018) Dietary magnesium intake and hyperuricemia among US adults. Nutrients 10, 296.
21.Huo, Y, Li, J, Qin, X, et al. (2015) Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313, 1325–1335.
22.Qin, X, Li, J, Zhang, Y, et al. (2016) Effect of folic acid supplementation on risk of new-onset diabetes in adults with hypertension in China: findings from the China Stroke Primary Prevention Trial (CSPPT). J Diabetes 8, 286–294.
23.Qin, X, Li, Y, He, M, et al. (2017) Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT). Am J Clin Nutr 105, 882–889.
24.Feig, DI, Kang, DH & Johnson, RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359, 1811–1821.
25.Levey, AS, Stevens, LA, Schmid, CH, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150, 604–612.
26.Croxford, R (2016) Restricted Cubic Spline Regression: A Brief Introduction. Toronto, ON: Institute for Clinical Evaluative Sciences.
27.Saliba, W, Barnett-Griness, O, Gronich, N, et al. (2019) Association of diabetes and glycated hemoglobin with the risk of intracerebral hemorrhage: a population-based cohort Study. Diabetes Care 42, 682–688.
28.Rubin, H (1975) Central role for magnesium in coordinate control of metabolism and growth in animal cells. Proc Natl Acad Sci U S A 72, 3551–3555.
29.Rubin, H (2005) Central roles of Mg2+ and MgATP2- in the regulation of protein synthesis and cell proliferation: significance for neoplastic transformation. Adv Cancer Res 93, 1–58.
30.Wolf, FI, Maier, JA, Nasulewicz, A, et al. (2007) Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys 458, 24–32.
31.Kim, DJ, Xun, P, Liu, K, et al. (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33, 2604–2610.
32.Dibaba, DT, Xun, P & He, K (2014) Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. Eur J Clin Nutr 68, 971.
33.Song, Y, Li, TY, van Dam, RM, et al. (2007) Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85, 1068–1074.
34.Lyngdoh, T, Marques-Vidal, P, Paccaud, F, et al. (2011) Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. Plos One 6, e19901.
35.Bonora, E, Targher, G, Zenere, MB, et al. (1996) Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20, 975–980.